Complete genome sequence of Streptomyces californicus ADR1, an anti-infective, anti-biofilm and anti-oxidant producing endophyte isolated from the medicinal plant Datura metel Authors: Khushboo Yadav, Sarika Phogat, Varsha Verma, Ashok K Dubey Published: 2026 ABSTRACT AbstractObjectiveStreptomyces californicus strain ADR1 is an endophytic actinobacterium isolated from Datura metel that produces secondary metabolites with potent antibacterial and anti-biofilm activities against WHO-listed high-priority Gram-positive pathogens. While anti-bacterial and antioxidant potential of the strain ADR1 has been extensively characterized, its complete genome sequence remains to be investigated for further insights into its biosynthetic potential. This study presents the complete genome sequence analysis of the strain ADR1 to provide a robust genomic foundation for understanding its metabolic versatility and biosynthesis of compounds with therapeutic significance.Data descriptionThe ADR1 genome was sequenced using Illumina HiSeq. The assembly comprised 262 scaffolds with a total genome size of 8.4 Mb and G + C content of 72.5%, containing 7427 protein-coding genes. AntiSMASH and IIT-Hyderabad novelBGC analysis revealed 39 biosynthetic gene clusters, including non-ribosomal peptide synthetases, type I polyketide synthases, terpene and melanin clusters, correlating with the diverse therapeutic compounds previously identified through GC-MS analysis. This high-quality genome provides crucial insights into the biosynthetic potential underlying potent antimicrobial and antioxidant activities of the strain ADR1.Supplementary InformationThe online version contains supplementary material available at https://doi.org/10.1186/s12863-026-01459-x.Keywords: Genome annotation, Genome assembly, Streptomyces californicus ADR1, Biosynthetic gene cluster, Secondary metabolites Objective The emergence of multidrug-resistant Gram-positive pathogens such as methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus faecium posed a serious threat to global health [1], necessitating urgent discovery of novel anti-infective agents. Endophytic actinobacteria represent an underexplored reservoir of therapeutic compounds, with Streptomyces species being particularly prolific producers of antibiotics and bioactive secondary metabolites [2–4]. However, repeat discovery of known molecules remains a significant challenge [5, 6]. S. californicus strain ADR1 was isolated from a medicinally important plant, Datura metel and was identified through 16 S rRNA gene sequence analysis [7]. The strain ADR1 produces potent secondary metabolites. Chemical profiling and GC-MS analysis of S. californicus ADR1 identified several therapeutically significant classes of compounds including alkaloids, terpenes, terpenoids, flavonoids, and glycosides [7]. Despite these promising bioactivities, the lack of a complete genome sequence for ADR1 limits our ability to mine its full biosynthetic potential and understand the genetic basis for its metabolic versatility. This Data Note presents the first complete genome sequence of the endophytic S. californicus ADR1, providing essential genomic resources for comparative studies and rational drug discovery. Data description The complete genome was sequenced using Illumina HiSeq (~ 99.5× coverage). Raw reads were quality-trimmed using Trimmomatic (Galaxy Version 0.39) and assembled with SPAdes (Galaxy Version 3.15.5). Genome completeness was assessed using BUSCO (Galaxy Version 5.5.0) achieving 99.91% completeness. There were 262 scaffolds, and the complete genome was 8.4 Mb in size with a GC content of 72.5%. Moreover, the whole genomic sequencing coverage rate was 99.5x. The taxonomic position of the strain ADR1 was determined by performing various analyses that included 16 S rRNA gene sequence analysis using BLASTn (https://blast.ncbi.nlm.nih.gov/Blast.cgi), 16 S rRNA gene phylogeny using Molecular Evolutionary Genetics analysis (MEGA 12) software (https://www.megasoftware.net/), whole-genome phylogeny, digital DNA-DNA hybridization (dDDH) using the TYGS platform (https://tygs.dsmz.de/), and average nucleotide identity (ANI) using EzBioCloud [8]. The 16 S rRNA sequence BLASTn gave 100 hits (including ADR1 available in NCBI database); 21 of these sequences showed percent identity of 99.17%, Query coverage of 100% and E-value = 0 (Additional file, Table 1). A total of 16 strains were used for the construction of 16 S rRNA gene phylogeny considering the standard taxonomic and phylogenetic guidelines as described in the Additional File. The 16 S rRNA gene phylogeny placed ADR1 in close association with S. californicus NBRC 3386 and NBRC 12,750 (Table 1, Data file 1). Since genome assemblies were unavailable for S. californicus NBRC 3386 and NBRC 12,750, whole genome (WG) phylogenetic construction was performed using WGS extracted from the final 16 S rRNA phylogeny with additional WG sequences of the strains selected from the top 100 BLASTn hits (Additional file). The WG phylogeny placed ADR1 within the S. californicus lineage and in close association with S. californicus DJ09 (Table 1, Data file 2). The species-level affiliation was further confirmed by ANI of 98.67% (> 96.7% threshold) and dDDH 88.5% (> 70% threshold) between S. californicus ADR1 and S. californicus DJ09 (Table 1, Data file 3). These combined analyses confirm that ADR1 represents a new strain of S. californicus. Table 1Overview of data files/data setsLabelName of data file/data setFile types (file extension)Data repository and identifier (DOI or accession number)Data file 116 S rRNA Phylogenetic tree of S. californicus ADR1 and related taxaMS Excel (.xlsx) https://doi.org/10.6084/m9.figshare.31940856.v3 [19]Data file 2Whole- genome Phylogenetic tree of S. californicus ADR1 and related taxaMS Excel (.xlsx)https://doi.org/10.6084/m9.figshare.31341079.v5 [20]Data file 3ANI and dDDH of S. californicus ADR1 with reference strainsMS Excel (.xlsx) https://doi.org/10.6084/m9.figshare.31341100.v4 [21]Data file 4Genome annotation of S. californicus ADR1MS Excel (.xlsx)https://doi.org/10.6084/m9.figshare.30833516.v2 [22]Data file 5tRNAs and rRNAs of S. californicus ADR1MS Excel (.xlsx)https://doi.org/10.6084/m9.figshare.30844304.v3 [23]Data file 6Circular representation of genome annotation of S. californicus ADR1Tagged image file format (.tif)https://doi.org/10.6084/m9.figshare.30834014.v1 [24]Data file 7Tandem repeats ofS. californicus ADR1MS Excel (.xlsx)https://doi.org/10.6084/m9.figshare.30834023.v3 [25]Data file 8Insertion sequence element ofS. californicus ADR1MS Excel (.xlsx)https://doi.org/10.6084/m9.figshare.30834110.v3 [26]Data file 9Gene prediction ofS. californicus ADR1Fasta file(.fasta)https://doi.org/10.6084/m9.figshare.30834266.v2 [27]Data file 10Functional annotation ofS. californicus ADR1 genomeMS Excel (.xlsx)https://doi.org/10.6084/m9.figshare.30834296.v3 [28]Data file 11Carbohydrate active enzymes ofS. californicus ADR1MS Excel (.xlsx)https://doi.org/10.6084/m9.figshare.30834314.v4 [29]Data file 12Anti-Microbial Resistance (AMR) ofS. californicus ADR1MS Excel (.xlsx)https://doi.org/10.6084/m9.figshare.30834617.v3 [30]Data file 13smBGCs ofS. californicus ADR1MS Excel (.xlsx)https://doi.org/10.6084/m9.figshare.30834329.v4 [31]Data set 1Genome assembly of S. californicus ADR1Fasta file (.fasta)GenBankhttp://identifiers.org/refseq.gcf:GCF_033441785.1 [32] Overview of data files/data sets https://doi.org/10.6084/m9.figshare.31940856.v3 [19] https://doi.org/10.6084/m9.figshare.31341100.v4 [21] Tandem repeats of S. californicus ADR1 Insertion sequence element of S. californicus ADR1 Gene prediction of S. californicus ADR1 Fasta file (.fasta) Functional annotation of S. californicus ADR1 genome Carbohydrate active enzymes of S. californicus ADR1 Anti-Microbial Resistance (AMR) of S. californicus ADR1 smBGCs of S. californicus ADR1 GenBank http://identifiers.org/refseq.gcf:GCF_033441785.1 [32] Genomic features were annotated utilizing DFAST (Table 1, Data file 4). The annotation gave 7427 protein coding genes and 6 CRISPR sequences. tRNAs were identified using tRNAscan (Galaxy Version 0.4), while rRNAs were detected with Barrnap (Galaxy Version 1.2.2) (Table 1, Data file 5). Circular representations of the genome have been presented in (Table 1, Data file 6) by using PROKSEE. Tandem repeats identification was performed using the eTandem tool (Galaxy Version 5.0.0.1) (Table 1, Data file 7). To identify insertion sequence elements in the genome of S. californicus ADR1, ISEScan (Galaxy Version 1.7.3) was used (Table 1, Data file 8). Gene prediction was done using prodigal gene predictor (Galaxy Version 2.6.3) (Table 1, Data file 9). Kyoto Encyclopedia of genes and genomes BlastKOALA was used for functional annotation (Table 1, Data file 10). Identification of genes that encode proteins with therapeutic value and industrial enzymes was conducted in two stages. The first stage was to obtain reference nucleotide sequences of each target enzyme (e.g., L-asparaginase, tyrosinase, uricase, alpha amylase etc.) in the open repositories including NCBI RefSeq. Second, these sequences were searched with BLASTn against the assembled genome of the isolate with stringent filters (E-value < 1 × 10⁻¹⁰, ≥ 80% identity, and ≥ 80% coverage). High confidence matches of various enzymes, including an asparaginase gene, a tyrosinase gene, a uricase gene and an amylase gene, were recovered using this pipeline, indicating that the genome does hold the genetic capability to generate therapeutic and industrial biocatalysts. L-asparaginase is clinically relevant for the treatment of acute lymphoblastic leukemia [9] and other anti-cancer therapeutic applications; uricase is also used in the enzyme replacement therapy of refractory gout and in tumor lysis syndrome [10, 11]. The α-Amylases are fundamentally valuable in the food and beverage processing industry [12, 13]. The identified tyrosinase locus provides biotechnological applications in the production of melanin and in oxidation reactions [14, 15]. The carbohydrate-active enzyme repertoire was analyzed using dbCAN3 [16] which predicted 143 CAZymes encoding genes that included 37 glycosyl transferases, 66 glycoside hydrolases, 4 carbohydrate esterases, 6 auxiliary activities, 2 polysaccharide lyases, and 28 carbohydrate-binding modules (Table 1, Data file 11). The outcome revealed that most of the results were contributed by the glycosyl transferases, glycoside hydrolases, and carbohydrate esterases. Such enzymes were identified to play a key role in production of secondary metabolites through the non-ribosomal pathway [17]. The detection of Anti-Microbial Resistance (AMR) within the genome was achieved through CARD (Table 1, Data file 12). To identify both, known and novel biosynthetic gene clusters (BGCs), anti-SMASH version 8.0.4 [18] and IIT Hyderabad novelBGC prediction server (https://project.iith.ac.in/sharmaglab/novelbgc/) was utilized (Table 1, Data file 13). 28 clusters, similar to the known BGCs, including polyketide synthases (8 clusters), non-ribosomal peptide synthetases (12 clusters), PKS-NRPS hybrids (2 clusters), terpene (4 clusters), RiPPs (10 clusters), ectoine, Lanthipeptide and melanin were identified along with their compound class. Interestingly, 10 new BGCs had a novelty score of > 0.5 (https://project.iith.ac.in/sharmaglab/novelbgc/680e70a8-c5bb-4868-a415-c01d35abbf59/all_analysis), which means that a cluster has less than 50% similarity in their gene content and organization with known BGCs and is thus regarded as putatively novel. This analysis was further supported with antiSMASH software in which these BGCs had no similarity score to known clusters which meant that close homologs of the clusters were not found in any reference databases and their possible role in encoding novel secondary metabolites or compounds. Thus, it is suggesting that S. californicus ADR1 has its own genetic potential in the production of the uncharacterized bioactive compounds, which makes it a good candidate for the discovery of new therapeutic agents. In conclusion, the genome sequence of strain ADR1 provides valuable insights into the genetic basis of its therapeutic and antimicrobial properties, identifying specific BGCs and a candidate therapeutic protein gene via BLASTn analysis. These findings indicate that S. californicus ADR1 could represent a promising resource for future genome mining exploration of antimicrobial and therapeutic agents. Limitations This study involved genome analysis for biosynthetic gene clusters (BGCs), and several limitations should be considered. The novelty assessment relies on similarity-based predictions generated using the IIT Hyderabad Novel BGC Prediction Server and antiSMASH, which are constrained by the completeness and accuracy of currently available reference databases. Therefore, novelty is defined relative to known and curated BGCs. The threshold of novelty score > 0.5 serves as a prioritization criterion rather than a definitive indicator of chemical novelty, as structurally related metabolites may still be produced by divergent gene clusters. Experimental validation was not performed in this study. As a result, the predicted metabolites, their chemical structures, and biological activities remain to be confirmed through future experimental approaches such as expression analysis, metabolite profiling, and compound isolation. Supplementary Information Below is the link to the electronic supplementary material. Supplementary Material 1 Abbreviations Benchmarking universal single copy orthologs Biosynthetic Gene Cluster Protein-coding DNA Sequence Non-ribosomal peptide synthetase Carbohydrate Active EnZymes Comprehensive Antibiotic Resistance database Polyketide synthase Ribosomal RNA Transfer RNA DDBJ Fast annotation and submission tool National center for biotechnology information Author contributions Khushboo analyzed the genome sequences and prepared the first draft of the manuscript. Sarika processed the raw genome data and prepared the assemblies. VV isolated the genome. The work was conceived and supervised by AKD. The manuscript was reviewed, revised and finalized by AKD. All authors agreed to the final version of the manuscript for publication. Funding No external funding was received for the work. It was funded by the internal grant of Netaji Subhas University of Technology. Data availability Data files 1–10 described in this Data note are freely and openly accessible on Figshare, https://figshare.com/account/mycontent/items.Data set 1 is available on the NCBI database [http://identifiers.org/refseq.gcf:GCF_033441785.1]( http:/identifiers.org/refseq.gcf:GCF_033441785.1). Decleration Ethics approval and consent to participate Not applicable. Consent for publication Not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Supplementary Materials Supplementary Material 1 Data Availability Statement Data files 1–10 described in this Data note are freely and openly accessible on Figshare, https://figshare.com/account/mycontent/items.Data set 1 is available on the NCBI database [http://identifiers.org/refseq.gcf:GCF_033441785.1]( http:/identifiers.org/refseq.gcf:GCF_033441785.1).